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BRIEF TECHNIQUE REPORTSFirst successful transapical aortic valve implantation after aortic
allograft replacement
Michael Schmoeckel, MD,a Peter Boekstegers, MD,b Konstantin Nikolaou, MD,c and Bruno Reichart, MD,a
Munich, GermanyAortic allograft reoperation may be difficult, especially
when the first procedure was done byminiroot replacement.1
We report the case of a 72-year-old patient with increasing
dyspnea from severe valvular regurgitation 13 years after
aortic allograft replacement and simultaneous coronary ar-
tery bypass grafting. A patent left internal thoracic artery
to the left anterior descending coronary artery and a venous
graft to a diagonal branch were seen on computed tomogra-
phy and angiography.
Because we had performed 33 transapical valve implanta-
tions (Edwards SAPIEN; Edwards Inc, Unterschleissheim,
Germany) with a 30 day mortality of 3%, we were confident
in the catheter-based implantation of a pericardial valve into
this calcified aortic allograft wall.
CLINICAL SUMMARY
In 1996, the 59-year-old male patient had undergone sur-
gery for aortic stenosis and coronary artery disease. At that
time, a 24-mm aortic allograft was implanted as a miniroot,
the left internal thoracic artery was anastomosed to the left
anterior descending coronary artery, and a saphenous vein
graft was connected to the second diagonal branch. Postop-
erative recovery was uneventful, and the patient did well
until the beginning of 2009, when he was seen with increas-
ing dyspnea.
Echocardiography showed severe aortic regurgitation
with a slightly dilated left ventricle but preserved perfor-
mance. The diagnosis was confirmed by aortography and
computed tomography, which demonstrated both bypass
grafts to be patent (Figure 1) and revealedmoderate to severe
calcifications within the aortic valve annulus and the wall of
the allograft. Annular diameter was measured at 23 3 25
mm, with distances from the annulus to the left coronary
artery of 12 mm and to the right coronary artery of 18 mm.
Because of the increased complexity of reoperative aortic
valve replacement in the presence of a heavily calcified allo-
graft wall and open bypass grafts, we discussed with the
patient the option of a catheter-based transapical aortic valve
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valve replacements after allograft implantation, we have
learned that in time allografts severely calcify within the
aortic annulus and wall, whereas the aortic leaflets are usu-
ally thin and friable,2 features that were verified by com-
puted tomographic scan in this case. Because valve
diameter (<25 mm) and distances to the coronary ostia
(both>9 mm) complied with the manufacturer recommen-
dations for transapical valve implantation, we preferred
this procedure.
Transapical valve implantation was performed in a hybrid
operating room by a team of cardiac surgeons, cardiologists,
and anesthesiologists. The chest was entered through an
anterolateral minithoracotomy in the 5th intercostal space.
The pericardium was incised over the apex, and a pacemaker
wire was attached to the left ventricle. After guidewire and
sheath positioning, a balloon aortic valvuloplasty was per-
formed to confirm the annular diameter and calculate the
necessary balloon filling volume. Then a 26-mm SAPIEN
pericardial valve was advanced into the aortic annulus and
expanded under rapid pacing. Intraoperative transesopha-
geal echocardiography and fluoroscopy confirmed only min-
imal aortic regurgitation (Figure 2).
FIGURE 1. Three-dimensional reconstruction of preoperative computed
tomographic scan. Arrows indicate open bypass grafts with left internal
thoracic artery (LIMA) to left anterior descending coronary artery and
saphenous vein graft (SVG) to second diagonal branch.rgery c October 2009
Brief Technique ReportsThe patient was transferred to our intensive care unit and
extubated in the afternoon of the same day. The postopera-
tive course was uneventful. Transthoracic echocardiography
of the prosthesis showed a maximum pressure gradient of
9 mm Hg and minimal eccentric aortic regurgitation.
DISCUSSION
Structural valve deterioration limits the long-term dura-
bility of both aortic xenografts and allografts. Ten years
after allograft replacement, the reported freedom from tis-
sue degeneration was 80%, and aortic valve reoperation
had to be performed in 18% of the patients.3 Technical
challenges common to any resternotomy and specific
problems related to allograft degeneration put patients
at risk.1 To avoid injury to patent bypass grafts and
FIGURE 2. Intraoperative aortography after deployment of transapical
valve (TAV). After removal of balloon catheter and guidewire through
sheath (arrow), only minimal aortic regurgitation was detected.The Journal of Thoracic and Cade´bridement of calcified tissue, a minimally invasive pro-
cedure appears attractive, especially in the elder age
group with multiple comorbidities. Transfemoral and
transapical aortic valve implantation routes have been
shown to be feasible alternatives for these patients in
the presence of aortic stenosis.4
An important prerequisite for success of the procedure is
sufficient calcification of the aortic annulus to support the
stented valve. Isolated aortic regurgitation of the native
aortic valve does not necessarily include calcification of
the annulus and is therefore not regarded as a typical indica-
tion for catheter-based aortic valve implantation.5 Structural
valve deterioration of allografts, however, in more than half
of affected patients leads to aortic regurgitation, which is ac-
companied by significant calcification of both annulus and
aortic wall.3 Under these conditions, catheter-based aortic
valve implantation is probably as safe as in patients with
aortic stenosis.
CONCLUSIONS
This first reported transapical aortic valve implantation
into an aortic allograft provides evidence that this proce-
dure is a feasible option in selected patients suffering
from structural valve deterioration after aortic allograft
replacement.
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